Pancreatic ductal adenocarcinoma (PDAC) is characterized by extremely poor prognosis. PDAC presents with molecularly distinct subtypes, with the basal-like one being associated with enhanced chemoresistance. Splicing dysregulation contributes to PDAC; however, its involvement in subtype specification remains elusive. Herein, we uncover a subtype-specific splicing signature associated with prognosis in PDAC and the splicing factor Quaking (QKI) as a determinant of the basal-like signature. Single-cell sequencing analyses highlight QKI as a marker of the basal-like phenotype. QKI represses splicing events associated with the classical subtype while promoting basal-like events associated with shorter survival. QKI favors a plastic, quasi-mesenchymal phenotype that supports migration and chemoresistance in PDAC organoids and cell lines, and its expression is elevated in high-grade primary tumors and metastatic lesions. These studies identify a splicing signature that defines PDAC subtypes and indicate that QKI promotes an undifferentiated, plastic phenotype, which renders PDAC cells chemoresistant and adaptable to environmental changes.

An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer / Ruta, V.; Naro, C.; Pieraccioli, M.; Leccese, A.; Archibugi, L.; Cesari, E.; Panzeri, V.; Allgower, C.; Arcidiacono, P. G.; Falconi, M.; Carbone, C.; Tortora, G.; Borrelli, F.; Attili, F.; Spada, C.; Quero, G.; Alfieri, S.; Doglioni, C.; Kleger, A.; Capurso, G.; Sette, C.. - In: CELL REPORTS MEDICINE. - ISSN 2666-3791. - 5:2(2024). [10.1016/j.xcrm.2024.101411]

An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer

Archibugi L.;Arcidiacono P. G.;Falconi M.;Doglioni C.;Capurso G.
Penultimo
;
2024-01-01

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extremely poor prognosis. PDAC presents with molecularly distinct subtypes, with the basal-like one being associated with enhanced chemoresistance. Splicing dysregulation contributes to PDAC; however, its involvement in subtype specification remains elusive. Herein, we uncover a subtype-specific splicing signature associated with prognosis in PDAC and the splicing factor Quaking (QKI) as a determinant of the basal-like signature. Single-cell sequencing analyses highlight QKI as a marker of the basal-like phenotype. QKI represses splicing events associated with the classical subtype while promoting basal-like events associated with shorter survival. QKI favors a plastic, quasi-mesenchymal phenotype that supports migration and chemoresistance in PDAC organoids and cell lines, and its expression is elevated in high-grade primary tumors and metastatic lesions. These studies identify a splicing signature that defines PDAC subtypes and indicate that QKI promotes an undifferentiated, plastic phenotype, which renders PDAC cells chemoresistant and adaptable to environmental changes.
2024
alternative splicing
chemoresistance
RNA processing
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S266637912400034X-main.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 5.71 MB
Formato Adobe PDF
5.71 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/160081
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact